| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 33 |
| 1 | SILDENAFIL CITRATE | 31 |
| 2 | MACITENTAN | 30 |
| 3 | OMEPRAZOLE MAGNESIUM | 26 |
| 4 | FUROSEMIDE | 25 |
| 5 | TREPROSTINIL | 23 |
| 6 | LEVOTHYROXINE SODIUM | 22 |
| 7 | OMEPRAZOLE | 22 |
| 8 | TADALAFIL | 22 |
| 9 | BOSENTAN | 18 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 58 |
| 1 | Proton Pump Inhibitor [EPC] | 34 |
| 2 | Prostacycline Vasodilator [EPC] | 31 |
| 3 | Corticosteroid [EPC] | 28 |
| 4 | Loop Diuretic [EPC] | 28 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 28 |
| 6 | Benzodiazepine [EPC] | 25 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 21 |
| 9 | Provitamin D2 Compound [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 2 | 0.0021 |
| 1 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 15 | 0.0006 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Endothelin Receptor Antagonist [EPC] | 58 | 0.0003 |
| 5 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 7 | Prostacycline Vasodilator [EPC] | 31 | 0.0002 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 28 | 0.0002 |
| 9 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |